2CDC.Preventuon and Control of Meningococcal Disease[J].MMWR,2005,54(RR-7):11-4.
3WHO.关于脑膜炎球菌疫苗的意见书.WER,2002,77(40):331-339.
4Gold R,Lepow M L,Gold scheneider I,et al.Antibody response of human infants to three doses of group A Neisseria meningitidis polysaccharide vaccine administered at two,four and six months of age[J].J Infect Dis,1978,138(6):731-735.
5Granoff D M,Gupta R K,Belshe R B,et al.Induction of immunological refractoriness in adults by meningococcal C polysaccharide vaccination[J].J Infect Dis,1998,178(3):870-874.
6Armand J,Arminjon,F,Mynard M C,et al.Tetravalent meningococcal polysaccharide vaccine group A,C,Y,W135:Clinical and serological evaluation[J].J Biol Stand,1982,10(4):335-339.
7Vodopija L,Baklaic Z,Hauser P,et al.Reactivity and immunogenicity of bivalent (A+C)and tetravalent(ACW135 Y)meningococcal vaccines containing O-acetyl-negative or O-acetyl-positive group C polysaccharide[J].Infect Immun,1983,42(2):599-604.
